News Events

DATE
ACTIVITY
LINK
2 Sep2026

Pareto Healthcare Conference, Stockholm. Carl-Johan Dalsgaard will present at this Scandinavian investor event that brings together leading healthcare providers, biotech innovators, and investors for financial presentations and panels.

31 Aug2026

DNB Carnegie “Small & Mid Cap Seminar”, Stockholm. CEO Carl-Johan Dalsgaard presents at the event.

21-25 Aug2026

Young Star Masters Grevagården, Skövde. Part of the sales team is representing Intervacc at this prestigious show jumping competition for young horses, attended by a large number of breeders, horse owners, and riders.

DATE
ACTIVITY
LINK
21 Aug2026

Redeye “Investor Update: Intervacc – Strangvac progress”. Carl-Johan Dalsgaard will present at the event, which will be streamed digitally between 11:00 AM and 12:30 PM (Swedish time).

21-24 Jul2026

Havemeyer Meeting, Kansas, USA. Workshops on equine research. Andrew Waller and Romain Pailott speak at the Havemeyer Foundation Workshop “Addressing Strangles and Other Streptococcal Diseases.” Supported by Boehringer Ingelheim Animal Health, Equine Diagnostic Solutions, Intervacc, and Merck Animal Health.

THE AGENDA

Activities in the calender

Sharing knowledge about strangles, biosecurity and preventive animal healthcare is an important part of Intervacc’s work. By actively participating in events attended by veterinarians and investors, we aim to promote greater understanding and contribute to better animal health.

This section presents key upcoming and past events involving Intervacc – from trade fairs, meetings and training sessions to scientific conferences and investor events.

DATE
ACTIVITY
LINK
2 Sep2026

Pareto Healthcare Conference, Stockholm. Carl-Johan Dalsgaard will present at this Scandinavian investor event that brings together leading healthcare providers, biotech innovators, and investors for financial presentations and panels.

31 Aug2026

DNB Carnegie “Small & Mid Cap Seminar”, Stockholm. CEO Carl-Johan Dalsgaard presents at the event.

21-25 Aug2026

Young Star Masters Grevagården, Skövde. Part of the sales team is representing Intervacc at this prestigious show jumping competition for young horses, attended by a large number of breeders, horse owners, and riders.

DATE
ACTIVITY
LINK
21 Aug2026

Redeye “Investor Update: Intervacc – Strangvac progress”. Carl-Johan Dalsgaard will present at the event, which will be streamed digitally between 11:00 AM and 12:30 PM (Swedish time).

21-24 Jul2026

Havemeyer Meeting, Kansas, USA. Workshops on equine research. Andrew Waller and Romain Pailott speak at the Havemeyer Foundation Workshop “Addressing Strangles and Other Streptococcal Diseases.” Supported by Boehringer Ingelheim Animal Health, Equine Diagnostic Solutions, Intervacc, and Merck Animal Health.

THE AGENDA

Upcoming activities

Raising awareness of strangles, infection control and preventive animal health is an important part of Intervacc’s work. By participating in trade fairs, meetings, training courses, conferences and lectures, we aim to contribute to greater knowledge and improved animal health.

Here we present major scheduled activities in which Intervacc participates.

Protein pattern
Three people are talking; in front of them there is a computer and a shelf with medicines.

With the news briefs, we want to offer an insight into the business between the regulatory news and the quarterly reports – which reflect the people, research, collaborations and activities behind the development of new vaccines and sales.

DNB Carnegie Cision

NEWS BRIEFS

2026-06-02 | SCIENTIFIC PUBLICATIONS
Studies Published on Zooepidemicus

Studies Published on Zooepidemicus

Intervacc’s Head of Research, Andrew Waller, and Head of Immunology, Romain Paillot, are co-authors of a new peer-reviewed and published article “Cross-protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies“.

2026-05-13 | FROM MEETINGS AND EVENTS
Annual General Meeting 2026

Annual General Meeting 2026

We were pleased to welcome approximately 30 shareholders and the majority of the Board of Directors to Intervacc’s Annual General Meeting, held at Cirio on Biblioteksgatan in Stockholm. This was the first opportunity for CEO Carl-Johan Dalsgaard to meet and introduce himself to the company’s shareholders in attendance.

If you are interested in the decisions made at the meeting – read more in the press release here »

2026-05-04 | IN THE FIGHT AGAINST STRANGLES
“Strangles Awareness Week”

“Strangles Awareness Week”

The annual initiative “Strangles Awareness Week” (SAW) is an international awareness campaign aimed at reducing the spread of strangles. SAW runs for one week—this year from 4–10 May.

Intervacc supports the campaign as part of the company’s long-term efforts to combat strangles. A key part of this work is education in general infection prevention and control.

Three people are talking; in front of them there is a computer and a shelf with medicines.

With our news items, we aim to offer insight into our operations between regulatory news and quarterly reports, reflecting the people, the research, the collaborations and the day-to-day work behind the development of new vaccines and sales.

DNB Carnegie Cision
2026-06-02 | SCIENTIFIC PUBLICATIONS
Studies Published on Zooepidemicus

Studies Published on Zooepidemicus

Intervacc’s Head of Research, Andrew Waller, and Head of Immunology, Romain Paillot, are co-authors of a new peer-reviewed and published article “Cross-protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies“.

2026-05-13 | FROM MEETINGS AND EVENTS
Annual General Meeting 2026

Annual General Meeting 2026

We were pleased to welcome approximately 30 shareholders and the majority of the Board of Directors to Intervacc’s Annual General Meeting, held at Cirio on Biblioteksgatan in Stockholm. This was the first opportunity for CEO Carl-Johan Dalsgaard to meet and introduce himself to the company’s shareholders in attendance.

If you are interested in the decisions made at the meeting – read more in the press release here »

2026-05-04 | IN THE FIGHT AGAINST STRANGLES
“Strangles Awareness Week”

“Strangles Awareness Week”

The annual initiative “Strangles Awareness Week” (SAW) is an international awareness campaign aimed at reducing the spread of strangles. SAW runs for one week—this year from 4–10 May.

Intervacc supports the campaign as part of the company’s long-term efforts to combat strangles. A key part of this work is education in general infection prevention and control.

NEWS BRIEFS

2026-06-02 | SCIENTIFIC PUBLICATIONS
Studies Published on Zooepidemicus

Studies Published on Zooepidemicus

Intervacc’s Head of Research, Andrew Waller, and Head of Immunology, Romain Paillot, are co-authors of a new peer-reviewed and published article “Cross-protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies“.

2026-05-13 | FROM MEETINGS AND EVENTS
Annual General Meeting 2026

Annual General Meeting 2026

We were pleased to welcome approximately 30 shareholders and the majority of the Board of Directors to Intervacc’s Annual General Meeting, held at Cirio on Biblioteksgatan in Stockholm. This was the first opportunity for CEO Carl-Johan Dalsgaard to meet and introduce himself to the company’s shareholders in attendance.

If you are interested in the decisions made at the meeting – read more in the press release here »

2026-05-04 | IN THE FIGHT AGAINST STRANGLES
“Strangles Awareness Week”

“Strangles Awareness Week”

The annual initiative “Strangles Awareness Week” (SAW) is an international awareness campaign aimed at reducing the spread of strangles. SAW runs for one week—this year from 4–10 May.

Intervacc supports the campaign as part of the company’s long-term efforts to combat strangles. A key part of this work is education in general infection prevention and control.